Fast Five Quiz: Next-Generation Sequencing in Non–Small Cell Lung Cancer

Nearly 30% of NSCLC harbor a mutation in the KRAS oncogene, making KRAS the most common oncogenic driver in lung cancer. The prevalence of mutations in the EGFR oncogenes overall is 19%, although it is much higher among Asian patients with lung adenocarcinoma. BRAF mutations occur in about 5% of patients. NTRK is rare, occurring in < 1% of patients.

Learn more about oncogenic driver mutations in NSCLC.

Medscape © 2022 WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Maurie Markman. Fast Five Quiz: Next-Generation Sequencing in Non–Small Cell Lung Cancer - Medscape - Aug 22, 2022.